QurAlis
Manuel N. is an esteemed expert in drug discovery and development with extensive leadership experience across multiple firms. Currently serving as a Drug Discovery and Development Advisor at QurAlis, Artugen Therapeutics, ClearB Therapeutics, and Stealth BioTherapeutics, Manuel N. also holds the position of Co-Founder at EnClear Therapies and Estabrook Pharmaceuticals, as well as at eXIthera Pharmaceuticals. Furthermore, leadership as President at Hub-Bio Strategic Advising and past tenure as Executive-in-Residence at Oxford Bioscience Partners underscore a robust professional background. Educational qualifications include a Doctor of Philosophy (PhD) and a Master of Science (MS) in Biophysics from the University of Chicago, alongside a Bachelor of Arts (BA) in Physics from New York University.
This person is not in any teams
This person is not in any offices
QurAlis
1 followers
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.